These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20558980)

  • 1. Outcomes of radical prostatectomy in clinically locally advanced N0M0 prostate cancer.
    Mearini L; Zucchi A; Costantini E; Bini V; Nunzi E; Porena M
    Urol Int; 2010; 85(2):166-72. PubMed ID: 20558980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of adjuvant radiotherapy after radical prostatectomy for prostate cancer patients.
    Suzuki K; Nakano K; Morita T
    Urol Int; 2010; 84(4):382-7. PubMed ID: 20224263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
    Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
    BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence.
    Boorjian SA; Thompson RH; Tollefson MK; Rangel LJ; Bergstralh EJ; Blute ML; Karnes RJ
    Eur Urol; 2011 Jun; 59(6):893-9. PubMed ID: 21388736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical prostatectomy for clinical T4 prostate cancer.
    Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
    Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of perineural invasion in 239 consecutive patients with pathologically organ-confined prostate cancer.
    Masieri L; Lanciotti M; Nesi G; Lanzi F; Tosi N; Minervini A; Lapini A; Carini M; Serni S
    Urol Int; 2010; 85(4):396-400. PubMed ID: 20516669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
    Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
    BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for and outcome of locally advanced prostate cancer after radical prostatectomy.
    Hsu CY; Wildhagen MF; Van Poppel H; Bangma CH
    BJU Int; 2010 Jun; 105(11):1536-40. PubMed ID: 19912180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy.
    Eggener SE; Roehl KA; Smith ND; Antenor JA; Han M; Catalona WJ
    J Urol; 2005 Apr; 173(4):1150-5. PubMed ID: 15758725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical recurrence following robot-assisted radical prostatectomy: analysis of 1384 patients with a median 5-year follow-up.
    Menon M; Bhandari M; Gupta N; Lane Z; Peabody JO; Rogers CG; Sammon J; Siddiqui SA; Diaz M
    Eur Urol; 2010 Dec; 58(6):838-46. PubMed ID: 20869162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
    Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML
    J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.
    Lughezzani G; Budäus L; Isbarn H; Sun M; Perrotte P; Haese A; Chun FK; Schlomm T; Steuber T; Heinzer H; Huland H; Montorsi F; Graefen M; Karakiewicz PI
    Eur Urol; 2010 Apr; 57(4):562-8. PubMed ID: 20018437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is radiotherapy useful in node-positive prostate cancer patients after radical prostatectomy?
    Van Poppel H
    Eur Urol; 2009 May; 55(5):1012-3. PubMed ID: 19261377
    [No Abstract]   [Full Text] [Related]  

  • 15. [The treatment of locally advanced (T3) prostatic carcinoma using radical prostatectomy or radiotherapy. A review].
    van den Ouden D; Schröder FH
    Tijdschr Gerontol Geriatr; 1998 Apr; 29(2):74-9. PubMed ID: 9615377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.
    Yossepowitch O; Eggener SE; Bianco FJ; Carver BS; Serio A; Scardino PT; Eastham JA
    J Urol; 2007 Aug; 178(2):493-9; discussion 499. PubMed ID: 17561152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer.
    Abdollah F; Gandaglia G; Suardi N; Capitanio U; Salonia A; Nini A; Moschini M; Sun M; Karakiewicz PI; Shariat SF; Montorsi F; Briganti A
    Eur Urol; 2015 Feb; 67(2):212-9. PubMed ID: 24882672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of positive resection margins in patients with pT2 prostate cancer. Implications for adjuvant treatment].
    Rosas-Nava JE; Herranz-Amo F; Paños-Fagundo EV; Lledó-García E; Verdú-Tartajo F; Hernández-Fernández C
    Actas Urol Esp; 2011 May; 35(5):272-6. PubMed ID: 21397985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis.
    Abdollah F; Suardi N; Cozzarini C; Gallina A; Capitanio U; Bianchi M; Sun M; Fossati N; Passoni NM; Fiorino C; Di Muzio N; Karakiewicz PI; Rigatti P; Montorsi F; Briganti A
    Eur Urol; 2013 Jun; 63(6):998-1008. PubMed ID: 23122664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis.
    Briganti A; Karnes RJ; Da Pozzo LF; Cozzarini C; Capitanio U; Gallina A; Suardi N; Bianchi M; Tutolo M; Salonia A; Di Muzio N; Rigatti P; Montorsi F; Blute M
    Eur Urol; 2011 May; 59(5):832-40. PubMed ID: 21354694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.